These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1876057)

  • 21. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients.
    Gold MS; Kleber HD
    Prog Clin Biol Res; 1981; 71():299-306. PubMed ID: 6276899
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ultrashort withdrawal from opiate dependence].
    Scherbaum N; Kienbaum P
    Med Monatsschr Pharm; 2003 Aug; 26(8):278-82. PubMed ID: 12953381
    [No Abstract]   [Full Text] [Related]  

  • 26. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML
    NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
    [No Abstract]   [Full Text] [Related]  

  • 28. Methadone maintenance treatment. When and how to refer patients.
    DeMaria PA; Weinstein SP
    Postgrad Med; 1995 Mar; 97(3):83-6, 91-2. PubMed ID: 7877931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.
    Verthein U; Ullmann R; Lachmann A; Düring A; Koch B; Meyer-Thompson HG; Schmidt R; Reimer J; Haasen C
    Drug Alcohol Depend; 2005 Nov; 80(2):267-71. PubMed ID: 15916866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Craving despite extremely high methadone dosage.
    de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
    Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodology for assessing agents that suppress methadone withdrawal: a study of baclofen.
    Jaffe JH; Kanzler M; Brady R; Friedman L
    NIDA Res Monogr; 1982 Apr; 41():269-75. PubMed ID: 6811918
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient perspectives of opiate withdrawal.
    Cohen AJ; Klett CJ; Ling W
    Drug Alcohol Depend; 1983 Oct; 12(2):167-72. PubMed ID: 6653388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metyrapone-induced withdrawal symptoms.
    Kennedy JA; Hartman N; Sbriglio R; Khuri E; Kreek MJ
    Br J Addict; 1990 Sep; 85(9):1133-40. PubMed ID: 2224193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alcohol abuse on progression of liver disease in methadone-maintained patients.
    Beverley CL; Kreek MJ; Wells AO; Curtis JL
    NIDA Res Monogr; 1979; 27():399-401. PubMed ID: 121359
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
    Eap CB
    Ann Pharmacother; 2000 Sep; 34(9):1077-8. PubMed ID: 10981259
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuro-electric therapy: criticisms of the 1984 Bethlem Study.
    Patterson MA
    Br J Addict; 1989 Jul; 84(7):818. PubMed ID: 2788020
    [No Abstract]   [Full Text] [Related]  

  • 39. The Bethlem Study on NET: putting the record straight.
    Gossop M; Strang J; Bradley B
    Br J Addict; 1989 Jul; 84(7):818-9. PubMed ID: 2667666
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing pathological detoxification fear among methadone maintenance patients: the DFSS.
    Milby JB; Gurwitch RH; Hohmann AA; Wiebe DJ; Ling W; McLellan AT; Woody GE
    J Clin Psychol; 1987 Sep; 43(5):528-38. PubMed ID: 3667947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.